Julinor Bacani

847 total citations
19 papers, 611 citations indexed

About

Julinor Bacani is a scholar working on Pathology and Forensic Medicine, Molecular Biology and Oncology. According to data from OpenAlex, Julinor Bacani has authored 19 papers receiving a total of 611 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Pathology and Forensic Medicine, 6 papers in Molecular Biology and 6 papers in Oncology. Recurrent topics in Julinor Bacani's work include Lymphoma Diagnosis and Treatment (5 papers), T-cell and Retrovirus Studies (3 papers) and Lung Cancer Treatments and Mutations (3 papers). Julinor Bacani is often cited by papers focused on Lymphoma Diagnosis and Treatment (5 papers), T-cell and Retrovirus Studies (3 papers) and Lung Cancer Treatments and Mutations (3 papers). Julinor Bacani collaborates with scholars based in Canada, United States and Netherlands. Julinor Bacani's co-authors include Steven Gallinger, Tony Pawson, Núria Malats, Harry Begthel, Elles M. J. Boon, Eduard Batlle, Steven T. Pals, Elena Sancho, Robert J. Ingham and Raymond Lai and has published in prestigious journals such as Nature, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Julinor Bacani

18 papers receiving 603 citations

Peers

Julinor Bacani
Iruvanti Sunitha United States
Manabu Shimoyama Japan
Man Jiang China
Robin Butler United Kingdom
Michael Friedrich Germany
Laurent Pangon Australia
Zhongzong Pan United States
Xiaoyan Zhong China
Marion Vogel Germany
Mohammad Abu-Odeh United States
Iruvanti Sunitha United States
Julinor Bacani
Citations per year, relative to Julinor Bacani Julinor Bacani (= 1×) peers Iruvanti Sunitha

Countries citing papers authored by Julinor Bacani

Since Specialization
Citations

This map shows the geographic impact of Julinor Bacani's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Julinor Bacani with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Julinor Bacani more than expected).

Fields of papers citing papers by Julinor Bacani

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Julinor Bacani. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Julinor Bacani. The network helps show where Julinor Bacani may publish in the future.

Co-authorship network of co-authors of Julinor Bacani

This figure shows the co-authorship network connecting the top 25 collaborators of Julinor Bacani. A scholar is included among the top collaborators of Julinor Bacani based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Julinor Bacani. Julinor Bacani is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
2.
Verhoeff, Kevin, et al.. (2022). A Cholangioblastic Variant of Cholangiocarcinoma. ACG Case Reports Journal. 9(2). e00746–e00746. 6 indexed citations
3.
EL‐Andari, Ryaan, et al.. (2022). Minocycline induced discoloration of the aortic intima and valve: A case report. Journal of Cardiac Surgery. 37(12). 5548–5550. 1 indexed citations
4.
Tessier‐Cloutier, Basile, David F. Schaeffer, Julinor Bacani, et al.. (2020). Loss of switch/sucrose non‐fermenting complex protein expression in undifferentiated gastrointestinal and pancreatic carcinomas. Histopathology. 77(1). 46–54. 38 indexed citations
5.
Lam, John C., et al.. (2020). Bartonella quintana infective endocarditis in northern Alberta: A case report. Journal of the Association of Medical Microbiology and Infectious Disease Canada. 5(4). 256–260. 4 indexed citations
6.
Ye, Carrie, et al.. (2019). An atypical case of Whipple’s disease presenting as fever of unknown origin: A brief review. Journal of the Association of Medical Microbiology and Infectious Disease Canada. 4(4). 241–247. 1 indexed citations
7.
Zhang, Jingxi, et al.. (2018). The c-Jun and JunB transcription factors facilitate the transit of classical Hodgkin lymphoma tumour cells through G1. Scientific Reports. 8(1). 16019–16019. 13 indexed citations
8.
Emamaullee, Juliet, et al.. (2018). Hepatic Epithelioid Hemangioendothelioma Presenting as an Enlarging Vascular Lesion within the Spleen. SHILAP Revista de lepidopterología. 2018. 1–3. 2 indexed citations
9.
Wu, Fang, Chenming Wu, L Li, et al.. (2015). NPM-ALK mediates phosphorylation of MSH2 at tyrosine 238, creating a functional deficiency in MSH2 and the loss of mismatch repair. Blood Cancer Journal. 5(5). e311–e311. 8 indexed citations
10.
Pearson, Joel D., et al.. (2014). Expression of granzyme B sensitizes ALK+ ALCL tumour cells to apoptosis-inducing drugs. Molecular Cancer. 13(1). 199–199. 11 indexed citations
11.
Chibbar, Richa, Julinor Bacani, & Sergio Zepeda-Gómez. (2013). Endoscopic Mucosal Resection of a Large Gastric Metastasis from Renal Cell Carcinoma. ACG Case Reports Journal. 1(1). 10–12. 4 indexed citations
12.
Bishop, Jennifer L., et al.. (2013). Lyn activity protects mice from DSS colitis and regulates the production of IL-22 from innate lymphoid cells. Mucosal Immunology. 7(2). 405–416. 39 indexed citations
13.
14.
Pearson, Joel D., Jason K. H. Lee, Julinor Bacani, Raymond Lai, & Robert J. Ingham. (2012). NPM-ALK: The Prototypic Member of a Family of Oncogenic Fusion Tyrosine Kinases. PubMed. 2012. 1–14. 35 indexed citations
15.
Pearson, Joel D., Jason K. H. Lee, Julinor Bacani, Raymond Lai, & Robert J. Ingham. (2011). NPM-ALK and the JunB transcription factor regulate the expression of cytotoxic molecules in ALK-positive, anaplastic large cell lymphoma.. PubMed. 4(2). 124–33. 20 indexed citations
16.
Zogopoulos, George, Claus Jørgensen, Julinor Bacani, et al.. (2008). Germline EPHB2 Receptor Variants in Familial Colorectal Cancer. PLoS ONE. 3(8). e2885–e2885. 14 indexed citations
17.
Bacani, Julinor, Nando Di Nicola, K. G. Mitchell, et al.. (2005). Tumor Microsatellite Instability in Early Onset Gastric Cancer. Journal of Molecular Diagnostics. 7(4). 465–477. 58 indexed citations
18.
Batlle, Eduard, Julinor Bacani, Harry Begthel, et al.. (2005). EphB receptor activity suppresses colorectal cancer progression. Nature. 435(7045). 1126–1130. 334 indexed citations
19.
Bardy, Peter, Julinor Bacani, Urve Kuusk, et al.. (1998). Correlation of CD44 expression with proliferative activity of normal human breast epithelial cells in culture. Breast Cancer Research and Treatment. 50(2). 143–153. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Iruvanti Sunitha Breakdown of academic impact, for papers by Manabu Shimoyama Breakdown of academic impact, for papers by Man Jiang Breakdown of academic impact, for papers by Robin Butler Breakdown of academic impact, for papers by Michael Friedrich Breakdown of academic impact, for papers by Laurent Pangon Breakdown of academic impact, for papers by Zhongzong Pan Breakdown of academic impact, for papers by Xiaoyan Zhong Breakdown of academic impact, for papers by Marion Vogel Breakdown of academic impact, for papers by Mohammad Abu-Odeh
Rankless by CCL
2026